Strikingly, neither HLX22 in combination with HLX02 nor HLX02 in combination with HLX11 induced caspase 3/7 activity in breast cancer cell line BT-474 and SKRB3 (Fig. 5c, d). The gene discussed is CASP3; the disease is breast cancer.